Elevated serum progesterone concentrations during the early follicular phase of the menstrual cycle: Clinical significance and therapeutic implications

Gynecological Endocrinology

Volumn 13, Issue 3, 1999, Pages 161-165

  Keck, C ^a   Neulen, J ^a   Breig Lauel, S ^a   Breckwoldt, M ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Adrenal insufficiency; Implantation; Progesterone

Indexed keywords

HYDROCORTISONE; HYDROXYPROGESTERONE; PRASTERONE SULFATE; PREDNISOLONE; PROGESTERONE; TESTOSTERONE;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; FOLLICULAR PHASE; HORMONE BLOOD LEVEL; HUMAN; INCIDENCE; INFERTILITY; INTRAUTERINE INSEMINATION; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; PREGNANCY; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; SEXUAL INTERCOURSE;

EID: 0032967510     PISSN: 09513590     EISSN: None     Source Type: Journal    
DOI: 10.3109/09513599909167550     Document Type: Article

References (18)

1. Schoolcraft W, Sinton E, Schlenker T, et al. Lower pregnancy rate with premature luteinization during pituitary suppression with leuprolide acetate. Fertil Steril 1991;55:563-6
2. Silverberg SG, Haukkamaa M, Arko H, et al. Endometrial morphology during long-term use of levonorgestrel-releasing intrauterine devices. Int J Gynecol Pathol 1986;5:235-41
3. Harada T, Yoshida S, Katagiri C, et al. Reduced implantation rate associated with a subtle rise in serum progesterone concentration during the follicular phase of cycles stimulated with a combination of a gonadotrophin-releasing hormone agonist and gonadotrophin. Hum Reprod 1995;10:1060-4
4. Mio Y, Sekijima A, Iwabe T, et al. Subtle rise in serum progesterone during the follicular phase as a predictor of the outcome of in vitro fertilization. Fertil Steril 1992;58:159-66
5. Fleming R, Coutts JRT. Induction of multiple follicular growth in normally menstruating women with endogenous gonadotropin suppression. Fertil Steril 1986;45:226-30
6. Gonen Y, Dirnfield M, Goldman S, et al. Preovulatory progesterone growth rate in patients treated with gonadotrophin-releasing hormone agonist and outcome of in vitro fertilization. Hum Reprod 1993;8:1376-9
7. Bourgain C, Smitz J, Camus M, et al. Human endometrial maturation is markedly improved after luteal supplementation of gonadotrophin-releasing hormone analogue/human menopausal gonadotrophin stimulated cycles. Hum Reprod 1994;9: 32-40
8. Dirnfeld M, Goldman S, Gonen Y, et al. A modest increase in serum progesterone levels on the day of human chorionic gonadotropin (hCG) administration may influence pregnancy rate and pregnancy loss in in vitro fertilization-embryo transfer (IVF-ET) patients. J Assist Reprod Genet 1993;10: 126-9
9. Fanchin R, de Ziegler D, Taieb J, et al. Premature elevation of plasma progesterone alters pregnancy rates of in vitro fertilization and embryo transfer. Fertil Steril 1993;59:1090-4
10. Sims JA, Seltman HJ, Muasher SJ. Early follicular rise of serum progesterone concentration in response to a flare-up effect of gonadotrophin-releasing hormone agonist impairs follicular recruitment for in vitro fertilization. Hum Reprod 1994;9:235-40
11. Judd S, Terry A, Petrucco M, et al. The source of pulsatile secretion of progesterone during the human follicular phase. J Clin Endocrinol Metabol 1992;74:299-305
12. New MI. Clinical and endocrinological aspects of 21-hydroxylase deficiency. Ann NY Acad Sci 1985;458:1-27
13. Saketos M, Sharma LOL, Santoro NF. Suppression of the hypothalamic-pituitary-ovarian axis in normal women by glucocorticoids. Biol Reprod 1993;49:1270-6
14. Kim-Bjorklund T, Landgren BM, Johannisson E. Morphometric studies of the endometrium, the fallopian tube and the corpus luteum during contraception with the 300 g norethisterone (NET) minipill. Contraception 1991;43: 459-74
15. Silverberg KM, Burns WN, Olive DL, et al. Serum progesterone levels predict success of in vitro fertilization/embryo transfer in patients stimulated with leuprolide acetate and human menopausal gonadotropin. J Clin Endocrinol Metabol 1991;73:797-803
16. Song JY, Markham R, Russell P, et al. The effect of high-dose medium- and long-term progestogen exposure on endometrial vessels. Hum Reprod 1995;10:797-800
17. Hourihan HM, Sheppard BL, Bonnar J. A morphometric study of the effect of oral norethisterone or levonorgestrel on endometrial blood vessels. Contraception 1986;34:603-12
18. Hourihan HM, Sheppard BL, Belsey EM, et al. Endometrial vascular features prior to and following exposure to levonorgestrel. Contraception 1991;43:375-85